Seborrheic Dermatitis
📧 Sign up to get email alerts when something new happens for Seborrheic Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-08-27FDA Approved: HALOBETASOL PROPIONATE — Supplemental Application (Coral Way Pharma, LLC)
FDA approved a supplemental application for halobetasol propionate filed by Coral Way Pharma, LLC.
-
FDA approval · 2020-02-18FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product l…
-
FDA approval · 2019-11-15FDA Approved: CLOBETASOL PROPIONATE — Original Application (Encube Ethicals, Inc.)
FDA approved the Original Application for Clobetasol Propionate Ointment USP, 0.05% (generic) by Encube Ethicals, Inc.
-
FDA approval · 2019-09-06FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for clobetasol propionate from Sun Pharmaceutical Industries, enhancing its approval under the gener…
-
CLINICAL_TRIALS trial_result · 2019-05-01Clinical Trial Update: Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis [Phase 2]
Phase 2 clinical trial update for omiganan BID in facial seborrheic dermatitis; current status unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-02-13FDA Approved: FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals' generic fluocinonide acetonide topical solution 0.01% (Original Application) for inflammatory and pruritic cor…
-
FDA approval · 2018-06-18FDA Approved: KETOCONAZOLE — Original Application (Strides Pharma Science Limited)
FDA approved Strides Pharma Science Limited's original ANDA for Ketoconazole, a generic antifungal product, covering common dermatophytic an…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis [Phase 3]
Phase 3 trial of tacrolimus ointment (PROTOPIC) for maintenance treatment of severe seborrheic dermatitis has completed.
-
FDA approval · 2018-04-17FDA Approved: CLOBETASOL PROPIONATE — Original Application (Xiromed, LLC)
FDA approved the original application for clobetasol propionate (topical) by Xiromed, LLC. It is a potent corticosteroid indicated for corti…
-
FDA approval · 2017-11-21FDA Approved: HYDROCORTISONE BUTYRATE — Original Application (The J. Molner Company LLC)
The FDA approved a generic topical hydrocortisone butyrate product under an Original Application (ANDA 209556) from The J. Molner Company LL…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo [NA]
Completed clinical trial comparing Ketoconazole 2% foam to Ketoconazole 2% shampoo for seborrheic dermatitis. Results were posted on 2017-11…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Neurobiology of the Scalp in Seborrheic Dermatitis
This clinical trial update notes that a study investigating the neurobiology of the scalp in seborrheic dermatitis has completed.
-
FDA approval · 2017-03-20FDA Approved: CLOBETASOL PROPIONATE — Original Application (Northstar Rx LLC)
FDA approved the original application for a generic clobetasol propionate topical corticosteroid, manufactured by Northstar Rx LLC. The appr…
-
FDA approval · 2016-12-13FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
The FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) from Royal Pharmaceuticals.
-
FDA label_change · 2016-11-02FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)
FDA approved a supplemental application for Tridesilon Cream (desonide 0.05%), updating the product labeling.
-
FDA approval · 2016-05-12FDA Approved: BETAMETHASONE DIPROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone Dipropionate from E. Fougera & Co., authorizing changes to the approved produc…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis [Phase 2]
Phase 2 study evaluating safety and efficacy of PAC-14028 Cream for seborrheic dermatitis has completed.
-
FDA approval · 2016-04-25FDA Approved: FLUOCINOLONE ACETONIDE OIL — Original Application (Rising Pharma Holdings, Inc.)
FDA approves Rising Pharma Holdings' Fluocinonide Acetonide Oil as a generic topical corticosteroid for inflammatory and pruritic skin condi…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis [NA]
A completed clinical trial evaluated the safety and efficacy of SEBORRHEAMEDIS Face Cream in participants with seborrheic dermatitis.
-
FDA approval · 2015-10-08FDA Approved: CICLOPIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Ciclopirox from Sun Pharmaceutical Industries, Inc., under the ANDA framework. The approval indi…
-
FDA approval · 2015-08-31FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
FDA approved a supplemental application for Ketoconazole from Thirty Madison Inc under an existing ANDA, signaling an approved modification …
-
FDA approval · 2014-07-18FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone from Sun Pharmaceutical Industries, updating or expanding its labeling.
-
FDA approval · 2014-07-14FDA Approved: FLUOCINONIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's Original Application for fluocinonide, a topical corticosteroid, as a generic product. This marks regulatory cle…
-
FDA label_change · 2014-04-02FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA supplemental application for HALOG (halcinonide cream) submitted by Sun Pharmaceutical Industries, Inc., with the submission status indi…
-
FDA approval · 2013-08-09FDA Approved: FLUOCINOLONE ACETONIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a generic topical fluocinonide acetonide product under an original application from Padagis Israel Pharmaceuticals Ltd.